Key Points
- EVP Edward Fargis sold 4,394 shares on March 6 at an average price of $23.15 for $101,721.10, leaving him with 88,660 shares (a 4.72% reduction valued at about $2.05M).
- Other senior insiders also sold significant positions in early March—CEO Parth Mehrotra sold about 63,439 shares (~$1.46M) and CFO David Mountcastle sold 11,006 shares (~$253K)—indicating notable insider liquidation activity.
- Despite the insider selling, Privia reported strong quarterly results (EPS $0.25 vs. $0.04 estimate; revenue $541.17M, up 17.4% YoY) and retains a consensus "Moderate Buy" from analysts with an average target of $31.00.
Privia Health Group, Inc. (NASDAQ:PRVA - Get Free Report) EVP Edward Fargis sold 4,394 shares of the stock in a transaction that occurred on Friday, March 6th. The stock was sold at an average price of $23.15, for a total transaction of $101,721.10. Following the transaction, the executive vice president directly owned 88,660 shares in the company, valued at approximately $2,052,479. This represents a 4.72% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.
Privia Health Group Stock Down 3.6%
Shares of PRVA opened at $22.47 on Wednesday. Privia Health Group, Inc. has a fifty-two week low of $18.77 and a fifty-two week high of $26.51. The company's fifty day moving average is $23.00 and its two-hundred day moving average is $23.61. The firm has a market cap of $2.78 billion, a PE ratio of 132.18, a price-to-earnings-growth ratio of 1.52 and a beta of 0.82.
Privia Health Group (NASDAQ:PRVA - Get Free Report) last released its quarterly earnings data on Thursday, February 26th. The company reported $0.25 EPS for the quarter, topping analysts' consensus estimates of $0.04 by $0.21. The business had revenue of $541.17 million during the quarter, compared to the consensus estimate of $516.61 million. Privia Health Group had a return on equity of 3.06% and a net margin of 1.08%.The business's revenue for the quarter was up 17.4% on a year-over-year basis. During the same period in the prior year, the firm posted $0.21 EPS. As a group, equities research analysts anticipate that Privia Health Group, Inc. will post 0.14 earnings per share for the current year.
Key Stories Impacting Privia Health Group
Here are the key news stories impacting Privia Health Group this week:
- Negative Sentiment: CEO Parth Mehrotra sold 21,440 shares on March 6 at $23.15 and 41,999 shares on March 9 at $22.86 (total ≈63,439 shares, ≈$1.46M). His holdings fell to 343,795 shares after the sales. CEO Form 4
- Negative Sentiment: CFO David Mountcastle completed two sales (5,177 shares on March 6 at $23.15 and 5,829 shares on March 9 at $22.84), totaling 11,006 shares (~$253k) and reducing his stake to ~161,903 shares. CFO Form 4
- Negative Sentiment: EVP Edward C. Fargis sold 4,394 shares on March 6 at $23.15 and 4,949 shares on March 9 at $22.84 (total 9,343 shares, ~ $215k), lowering his holding to ~83,711 shares. EVP Form 4
Institutional Inflows and Outflows
Hedge funds have recently added to or reduced their stakes in the stock. Royal Bank of Canada boosted its position in shares of Privia Health Group by 63.5% in the first quarter. Royal Bank of Canada now owns 245,633 shares of the company's stock worth $5,514,000 after buying an additional 95,371 shares during the period. AQR Capital Management LLC raised its holdings in shares of Privia Health Group by 24.7% during the 1st quarter. AQR Capital Management LLC now owns 40,781 shares of the company's stock valued at $916,000 after buying an additional 8,068 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its position in Privia Health Group by 3.2% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 118,764 shares of the company's stock worth $2,666,000 after acquiring an additional 3,714 shares in the last quarter. Intech Investment Management LLC lifted its position in Privia Health Group by 55.1% during the 1st quarter. Intech Investment Management LLC now owns 56,553 shares of the company's stock worth $1,270,000 after acquiring an additional 20,082 shares in the last quarter. Finally, Acadian Asset Management LLC purchased a new position in Privia Health Group in the 1st quarter worth approximately $154,000. 94.48% of the stock is owned by hedge funds and other institutional investors.
Analysts Set New Price Targets
A number of equities analysts have recently commented on the company. Wolfe Research set a $31.00 price objective on Privia Health Group in a report on Tuesday, January 6th. Weiss Ratings reiterated a "hold (c)" rating on shares of Privia Health Group in a report on Monday, December 29th. Royal Bank Of Canada started coverage on shares of Privia Health Group in a research report on Friday, January 9th. They set an "outperform" rating and a $31.00 target price for the company. JPMorgan Chase & Co. raised their price target on shares of Privia Health Group from $32.00 to $33.00 and gave the company an "overweight" rating in a report on Thursday, November 13th. Finally, BMO Capital Markets began coverage on shares of Privia Health Group in a research report on Thursday, November 13th. They set an "outperform" rating and a $30.00 price target on the stock. Thirteen investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company's stock. According to MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average target price of $31.00.
Read Our Latest Analysis on Privia Health Group
About Privia Health Group
(
Get Free Report)
Privia Health Group (NASDAQ: PRVA) is a physician enablement company that partners with independent physicians, medical groups and health systems to transform the delivery of patient care. Through a clinically integrated network and a proprietary technology platform, the company supports providers in managing population health, delivering coordinated care and optimizing financial performance under both fee-for-service and value-based reimbursement models.
Founded in 2016 and headquartered in McLean, Virginia, Privia Health has rapidly expanded its footprint to serve multiple metropolitan markets across the United States.
Read More
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
